Filling the gap in scleral lens application with ScleralEase

Mile Brujic, OD, FAAO, partner at Premier Vision Group in Northwest Ohio, describes the development and launch of ScleralEase, a dual-purpose tool designed to both apply and remove scleral lenses. The product is currently patent pending and available for clinicians to order for their practices.

The idea arose directly from patient feedback: many scleral lens wearers repeatedly asked if there was a more convenient, simplified way to handle their lenses. Recognizing a gap in available products—and noting that clinicians rarely pause to ask how to simplify these processes—he began exploring whether a single device could integrate both an applicator and a remover.

Unable to find an existing solution online, Brujic created the first prototype himself by cutting and combining 2 existing devices to form a 3D representation of his concept. Early patient experiences with prototypes were strongly positive, particularly around the convenience of having 2 functions in 1 device and a more substantial, ergonomic form factor that was easier to grip and maneuver.

For manufacturing, Brujic chose to partner with Contamac, a well-established company in eye care with existing production capabilities. Rather than building manufacturing infrastructure from scratch, he leveraged Contamac’s facilities and expertise. They quickly expressed interest, committed to the project, and successfully brought the design into production.

Brujic detailed several functional and design features of ScleralEase. One end is small for lens removal, while the larger end is used for application. The device incorporates side holes that can be covered to create suction or left open to avoid suction, mimicking and consolidating the roles of multiple traditional tools. Its shape is intentionally reminiscent of an eyeball with upper and lower lids, reinforcing the eye-care context. A small cutaway “lip” on the top end provides an additional function: when wetted and gently “squeegeed” across the ocular surface, it helps create a temporarily more wettable surface for lenses that may not rehydrate well from a dry state.

Implementation for clinicians is intentionally straightforward. ODs can purchase ScleralEase through the Contamac website, either for wholesale use or retail resale to patients. Patient education is minimal because the design is intuitive; the main teaching point is that the suction mechanism operates opposite to traditional large DMV devices, requiring application of pressure followed by a subtle release while maintaining some contact.

Brujic also offers broader guidance for clinicians interested in designing tools or devices. He noted that some colleagues have substantial manufacturing or industry experience, while others are starting from scratch. Those without existing connections should focus on building relationships—either directly with manufacturers or via partnerships with established companies. He stressed the importance of non-disclosure agreements (NDAs) to protect ideas during early discussions and encourages clinicians to consider whether their concept warrants a provisional and then utility patent. While the process can seem daunting, she cautions against letting that intimidation halt innovation.

In closing, Brujic reflected that ScleralEase was roughly 2 years in development and officially launched in January. He is proud of the outcome and urges colleagues not to accept the status quo in clinical practice. Instead, he advocates continually questioning existing workflows, identifying gaps in patient care or convenience, and collaborating with peers and industry partners to turn innovative ideas into practical solutions.